NP-G2-044

· Novita Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NP-G2-044, covering 2025-07-20 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]

See pricing